ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002